Product Information
Name:SN-38 Glucuronide
Synonyms:
- β-D-Glucopyranosiduronic acid
- (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl
- β-D-Glucopyranosiduronic acid
- 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl
- (S)-
- (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl β-D-glucopyranosiduronic acid
- SN 38G
- 10-Hydroxy-7-ethylcamptothecin 10-β-D-glucuronide
- 7-Ethyl-10-hydroxy-20(S)-camptothecin 10-β-D-glucuronide
- 7-Ethyl-10-hydroxycamptothecin 10-β-D-glucuronide
- (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione 9-(β-D-glucopyranosiduronide)
- See more synonyms
Brand:TRC
Description:Applications A metabolite of IrinotecanReferences Fujita, K., et al.: Biol. Pharm. Bull., 31, 2137 (2008), Sandanaraj, E., et al.: Pharmacogen. J., 8, 174 (2008), Chen, K., et al.: Chem. Biol., 15, 1277 (2008), Prijovich, Z., et al.: Mol. Canc. Ther., 8, 940 (2009),
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:568.53
Formula:C28H28N2O11
Color/Form:White To Yellow
InChI:InChI=1S/C28H28N2O11/c1-3-12-13-7-11(40-26-22(33)20(31)21(32)23(41-26)25(35)36)5-6-17(13)29-19-14(12)9-30-18(19)8-16-15(24(30)34)10-39-27(37)28(16,38)4-2/h5-8,20-23,26,31-33,38H,3-4,9-10H2,1-2H3,(H,35,36)/t20-,21-,22+,23-,26+,28-/m0/s1
InChI key:InChIKey=SSJQVDUAKDRWTA-CAYKMONMSA-N
SMILES:CCc1c2c(nc3ccc(O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
Technical inquiry about: SN-38 Glucuronide
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
